ALYREF (Aly/REF export factor): A potential biomarker for predicting cancer occurrence and therapeutic efficacy.

[1]  Xu Zhang,et al.  LINC02159 promotes non-small cell lung cancer progression via ALYREF/YAP1 signaling , 2023, Molecular Cancer.

[2]  B. Dong,et al.  m5C-dependent cross-regulation between nuclear reader ALYREF and writer NSUN2 promotes urothelial bladder cancer malignancy through facilitating RABL6/TK1 mRNAs splicing and stabilization , 2023, Cell Death & Disease.

[3]  Na Li,et al.  Ovarian cancer subtypes based on the regulatory genes of RNA modifications: Novel prediction model of prognosis , 2022, Frontiers in Endocrinology.

[4]  Yiming Ma,et al.  Identification of a novel m5C/m6A-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma , 2022, Frontiers in Genetics.

[5]  Jeffrey T. Chang,et al.  Human NOP2/NSUN1 regulates ribosome biogenesis through non-catalytic complex formation with box C/D snoRNPs , 2022, bioRxiv.

[6]  Xiao Zhang,et al.  YAP 5-methylcytosine modification increases its mRNA stability and promotes the transcription of exosome secretion-related genes in lung adenocarcinoma , 2022, Cancer Gene Therapy.

[7]  G. Calin,et al.  ALYREF, a novel factor involved in breast carcinogenesis, acts through transcriptional and post-transcriptional mechanisms selectively regulating the short NEAT1 isoform , 2022, Cellular and Molecular Life Sciences.

[8]  Xin-yu Li,et al.  Correlation Between the RNA Methylation Genes and Immune Infiltration and Prognosis of Patients with Hepatocellular Carcinoma: A Pan-Cancer Analysis , 2022, Journal of inflammation research.

[9]  Yuting Su,et al.  LncRNA Pnky Positively Regulates Neural Stem Cell Migration by Modulating mRNA Splicing and Export of Target Genes , 2022, Cellular and Molecular Neurobiology.

[10]  Weiqi Wang,et al.  ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma , 2022, Translational oncology.

[11]  P. Yi,et al.  RNA 5-Methylcytosine Regulators Contribute to Metabolism Heterogeneity and Predict Prognosis in Ovarian Cancer , 2022, Frontiers in Cell and Developmental Biology.

[12]  Peiwu Li,et al.  Exploration of Potential Roles of m5C-Related Regulators in Colon Adenocarcinoma Prognosis , 2022, Frontiers in Genetics.

[13]  Qiaofeng Zhang,et al.  The role of RNA m5C modification in cancer metastasis , 2021, International journal of biological sciences.

[14]  G. Jia,et al.  RNA methylation in mammalian development and cancer , 2021, Cell Biology and Toxicology.

[15]  X. Yang,et al.  The role of the HIF‐1α/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer , 2021, Cancer communications.

[16]  P. Guo,et al.  Effects of Adenine Methylation on the Structure and Thermodynamic Stability of a DNA Minidumbbell , 2021, International Journal of Molecular Sciences.

[17]  Cizhong Jiang,et al.  An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability , 2021, Nature communications.

[18]  Yu-Sheng Chen,et al.  Dynamic transcriptomic m5C and its regulatory role in RNA processing , 2021, Wiley interdisciplinary reviews. RNA.

[19]  Yuchen Li,et al.  ALYREF Drives Cancer Cell Proliferation Through an ALYREF-MYC Positive Feedback Loop in Glioblastoma , 2021, OncoTargets and therapy.

[20]  Yutong Meng,et al.  Expression and prognostic characteristics of m5C regulators in low‐grade glioma , 2021, Journal of cellular and molecular medicine.

[21]  A. Jemal,et al.  Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.

[22]  Xin Xu,et al.  NSun2 promotes cell migration through methylating autotaxin mRNA , 2020, The Journal of Biological Chemistry.

[23]  Yuanyuan Zhang,et al.  Gene signatures of m5C regulators may predict prognoses of patients with head and neck squamous cell carcinoma. , 2020, American journal of translational research.

[24]  Zhihong Wu,et al.  Target RNA modification for epigenetic drug repositioning in neuroblastoma: computational omics proximity between repurposing drug and disease , 2020, Aging.

[25]  Jianlong Wang,et al.  Functional role of Tet-mediated RNA hydroxymethylcytosine in mouse ES cells and during differentiation , 2020, Nature Communications.

[26]  Jiadong Wang,et al.  Suppression of DDX39B sensitizes ovarian cancer cells to DNA-damaging chemotherapeutic agents via destabilizing BRCA1 mRNA , 2020, Oncogene.

[27]  Yuting He,et al.  Role of m 5 C-related regulatory genes in the diagnosis and prognosis of hepatocellular carcinoma , 2020 .

[28]  Sung Soo Ahn,et al.  Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma , 2020, Scientific Reports.

[29]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[30]  H. Cui,et al.  Depletion of TRDMT1 affects 5-methylcytosine modification of mRNA and inhibits HEK293 cell proliferation and migration. , 2019, Biochemical and biophysical research communications.

[31]  David P. Kreil,et al.  Loss of the ribosomal RNA methyltransferase NSUN5 impairs global protein synthesis and normal growth , 2019, Nucleic acids research.

[32]  Neil Vasan,et al.  A view on drug resistance in cancer , 2019, Nature.

[33]  Zheng Wang,et al.  NOP2/Sun RNA methyltransferase 2 promotes tumor progression via its interacting partner RPL6 in gallbladder carcinoma , 2019, Cancer science.

[34]  Ahmedin Jemal,et al.  Cancer treatment and survivorship statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[35]  Jun Xia,et al.  RNA 5-Methylcytosine Facilitates the Maternal-to-Zygotic Transition by Preventing Maternal mRNA Decay. , 2019, Molecular cell.

[36]  P. Pandolfi,et al.  Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program , 2019, Acta Neuropathologica.

[37]  Dan Xie,et al.  5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs , 2019, Nature Cell Biology.

[38]  R. C. Poulos,et al.  JMJD6 is a tumorigenic factor and therapeutic target in neuroblastoma , 2019, Nature Communications.

[39]  S. Piccolo,et al.  YAP and TAZ: a signalling hub of the tumour microenvironment , 2019, Nature Reviews Cancer.

[40]  Abdulrahim A. Sajini,et al.  Loss of 5-methylcytosine alters the biogenesis of vault-derived small RNAs to coordinate epidermal differentiation , 2019, Nature Communications.

[41]  Rui Zhang,et al.  Genome-wide identification of mRNA 5-methylcytosine in mammals , 2019, Nature Structural & Molecular Biology.

[42]  Michaela Frye,et al.  RNA modifications regulating cell fate in cancer , 2019, Nature Cell Biology.

[43]  Hunseung Kang,et al.  Epitranscriptomic RNA Methylation in Plant Development and Abiotic Stress Responses , 2019, Front. Plant Sci..

[44]  B. Cullen,et al.  Extensive Epitranscriptomic Methylation of A and C Residues on Murine Leukemia Virus Transcripts Enhances Viral Gene Expression , 2019, mBio.

[45]  Ava Kwong,et al.  Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness , 2019, Cell Death & Disease.

[46]  M. Bohnsack,et al.  Eukaryotic 5-methylcytosine (m5C) RNA Methyltransferases: Mechanisms, Cellular Functions, and Links to Disease , 2019, Genes.

[47]  E. Wang,et al.  Archaeal NSUN6 catalyzes m5C72 modification on a wide-range of specific tRNAs , 2018, Nucleic acids research.

[48]  G. Cisneros,et al.  Selectivity and Promiscuity in TET-Mediated Oxidation of 5-Methylcytosine in DNA and RNA. , 2018, Biochemistry.

[49]  A. Lusser,et al.  The dynamic RNA modification 5‐methylcytosine and its emerging role as an epitranscriptomic mark , 2018, Wiley interdisciplinary reviews. RNA.

[50]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[51]  Guohui Li,et al.  mRNAs are sorted for export or degradation before passing through nuclear speckles , 2018, Nucleic acids research.

[52]  Stuart A. Wilson,et al.  Co-transcriptional Loading of RNA Export Factors Shapes the Human Transcriptome , 2018, bioRxiv.

[53]  Chuan He,et al.  RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia , 2018, Nature Communications.

[54]  Nan Li,et al.  Tet2 promotes pathogen infection-induced myelopoiesis through mRNA oxidation , 2018, Nature.

[55]  J. Troppmair,et al.  RNA cytosine methyltransferase Nsun3 regulates embryonic stem cell differentiation by promoting mitochondrial activity , 2017, Cellular and Molecular Life Sciences.

[56]  Tomasz K. Wirecki,et al.  MODOMICS: a database of RNA modification pathways. 2017 update , 2017, Nucleic Acids Res..

[57]  John S. Mattick,et al.  The RNA modification landscape in human disease , 2017, RNA.

[58]  Guohui Li,et al.  ALYREF mainly binds to the 5′ and the 3′ regions of the mRNA in vivo , 2017, Nucleic acids research.

[59]  Sharmistha Banerjee,et al.  Cytosine methylation by DNMT2 facilitates stability and survival of HIV-1 RNA in the host cell during infection. , 2017, The Biochemical journal.

[60]  Tsutomu Suzuki,et al.  ALKBH1 is an RNA dioxygenase responsible for cytoplasmic and mitochondrial tRNA modifications , 2017, Nucleic acids research.

[61]  Samir Adhikari,et al.  5-methylcytosine promotes mRNA export — NSUN2 as the methyltransferase and ALYREF as an m5C reader , 2017, Cell Research.

[62]  H. Al‐Hashimi,et al.  Insights into Watson–Crick/Hoogsteen breathing dynamics and damage repair from the solution structure and dynamic ensemble of DNA duplexes containing m1A , 2017, Nucleic acids research.

[63]  Tingting Zou,et al.  Human m6A writers: Two subunits, 2 roles , 2017, RNA biology.

[64]  Jun Li,et al.  Transcriptome-Wide Mapping of RNA 5-Methylcytosine in Arabidopsis mRNAs and Noncoding RNAs , 2017, Plant Cell.

[65]  Jun Yao,et al.  A ROR1-HER3-LncRNA signaling axis modulates the Hippo-YAP pathway to regulate bone metastasis , 2017, Nature Cell Biology.

[66]  S. Dietmann,et al.  Cytosine-5 RNA Methylation Regulates Neural Stem Cell Differentiation and Motility , 2016, Stem cell reports.

[67]  M. Rodnina,et al.  NSUN3 and ABH1 modify the wobble position of mt‐tRNA Met to expand codon recognition in mitochondrial translation , 2016, The EMBO journal.

[68]  Tsutomu Suzuki,et al.  NSUN3 methylase initiates 5-formylcytidine biogenesis in human mitochondrial tRNA(Met). , 2016, Nature chemical biology.

[69]  Jizhen Li,et al.  5-hydroxymethylcytosine is detected in RNA from mouse brain tissues , 2016, Brain Research.

[70]  R. Montironi,et al.  Metabolic phenotype of bladder cancer. , 2016, Cancer treatment reviews.

[71]  James A. Swenberg,et al.  DNA methylation on N6-adenine in mammalian embryonic stem cells , 2016, Nature.

[72]  Ingrid M. Montes-Rodríguez,et al.  Pathway Analysis using Gene-expression Profiles of HPV-positive and HPV-negative Oropharyngeal Cancer Patients in a Hispanic Population: Methodological Procedures. , 2016, Puerto Rico health sciences journal.

[73]  Lin Xu,et al.  PKM2 and cancer: The function of PKM2 beyond glycolysis , 2016, Oncology letters.

[74]  Fan Zhang,et al.  Deposition of 5-Methylcytosine on Enhancer RNAs Enables the Coactivator Function of PGC-1α. , 2016, Cell reports.

[75]  Fei Wang,et al.  Transcriptome-wide distribution and function of RNA hydroxymethylcytosine , 2016, Science.

[76]  Bifeng Yuan,et al.  The existence of 5-hydroxymethylcytosine and 5-formylcytosine in both DNA and RNA in mammals. , 2016, Chemical communications.

[77]  Rui Henrique,et al.  Diagnostic and prognostic epigenetic biomarkers in cancer. , 2015, Epigenomics.

[78]  M. Bohnsack,et al.  NSUN6 is a human RNA methyltransferase that catalyzes formation of m5C72 in specific tRNAs , 2015, RNA.

[79]  M. Goodell,et al.  New answers to old questions from genome-wide maps of DNA methylation in hematopoietic cells. , 2014, Experimental hematology.

[80]  F. Berthold,et al.  Chromosome 17/17q gain and unaltered profiles in high resolution array‐CGH are prognostically informative in neuroblastoma , 2014, Genes, chromosomes & cancer.

[81]  G. Pfeifer,et al.  Tet-Mediated Formation of 5-Hydroxymethylcytosine in RNA , 2014, Journal of the American Chemical Society.

[82]  Kwok-Kin Wong,et al.  Non-small-cell lung cancers: a heterogeneous set of diseases , 2014, Nature Reviews Cancer.

[83]  B. Habermann,et al.  NSUN4 Is a Dual Function Mitochondrial Protein Required for Both Methylation of 12S rRNA and Coordination of Mitoribosomal Assembly , 2014, PLoS genetics.

[84]  P. Delgado-Olguín,et al.  Expression of NOL1/NOP2/sun domain (Nsun) RNA methyltransferase family genes in early mouse embryogenesis. , 2013, Gene expression patterns : GEP.

[85]  Yi Zhang,et al.  TET enzymes, TDG and the dynamics of DNA demethylation , 2013, Nature.

[86]  K. Uzawa,et al.  ALY as a potential contributor to metastasis in human oral squamous cell carcinoma , 2013, Journal of Cancer Research and Clinical Oncology.

[87]  Michaela Frye,et al.  The Mouse Cytosine-5 RNA Methyltransferase NSun2 Is a Component of the Chromatoid Body and Required for Testis Differentiation , 2013, Molecular and Cellular Biology.

[88]  Stuart A. Wilson,et al.  Chtop is a component of the dynamic TREX mRNA export complex , 2013, EMBO Journal.

[89]  A. Fullaondo,et al.  The Nuclear Protein ALY Binds to and Modulates the Activity of Transcription Factor E2F2* , 2013, Molecular & Cellular Proteomics.

[90]  M. García-Díaz,et al.  Structure of the essential MTERF4:NSUN4 protein complex reveals how an MTERF protein collaborates to facilitate rRNA modification. , 2012, Structure.

[91]  B. Golinelli‐Pimpaneau,et al.  The human tRNA m5C methyltransferase Misu is multisite-specific , 2012, RNA biology.

[92]  T. Preiss,et al.  Widespread occurrence of 5-methylcytosine in human coding and non-coding RNA , 2012, Nucleic acids research.

[93]  J. Nichols,et al.  The RNA–Methyltransferase Misu (NSun2) Poises Epidermal Stem Cells to Differentiate , 2011, PLoS genetics.

[94]  Wenyong Zhang,et al.  Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. , 2011, Blood.

[95]  E. Scarpi,et al.  Peritoneal carcinomatosis from ovarian cancer: chemosensitivity test and tissue markers as predictors of response to chemotherapy , 2011, Journal of Translational Medicine.

[96]  B. Habermann,et al.  MTERF4 regulates translation by targeting the methyltransferase NSUN4 to the mammalian mitochondrial ribosome. , 2011, Cell metabolism.

[97]  R. Luna,et al.  Differential expression of THOC1 and ALY mRNP biogenesis/export factors in human cancers , 2011, BMC Cancer.

[98]  Steven P Gygi,et al.  ATP is required for interactions between UAP56 and two conserved mRNA export proteins, Aly and CIP29, to assemble the TREX complex. , 2010, Genes & development.

[99]  Yi Zhang,et al.  Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification , 2010, Nature.

[100]  D. Tollervey,et al.  The Many Pathways of RNA Degradation , 2009, Cell.

[101]  P. Wen,et al.  Phase II Study of Protracted Daily Temozolomide for Low-Grade Gliomas in Adults , 2008, Clinical Cancer Research.

[102]  Frank Lyko,et al.  RNA cytosine methylation analysis by bisulfite sequencing , 2008, Nucleic acids research.

[103]  N. Liabakk,et al.  Human AlkB Homolog 1 Is a Mitochondrial Protein That Demethylates 3-Methylcytosine in DNA and RNA* , 2008, Journal of Biological Chemistry.

[104]  Albert Jeltsch,et al.  Human DNMT2 methylates tRNA(Asp) molecules using a DNA methyltransferase-like catalytic mechanism. , 2008, RNA.

[105]  P. Agris.  Bringing order to translation: the contributions of transfer RNA anticodon‐domain modifications , 2008, EMBO reports.

[106]  M. Okada,et al.  Akt phosphorylation and nuclear phosphoinositide association mediate mRNA export and cell proliferation activities by ALY , 2008, Proceedings of the National Academy of Sciences.

[107]  M. Karamouzis,et al.  Head and neck cancer , 2008, The Lancet.

[108]  J. Schimenti,et al.  Sperm Motility Defects and Infertility in Male Mice with a Mutation in Nsun7, a Member of the Sun Domain-Containing Family of Putative RNA Methyltransferases1 , 2007, Biology of reproduction.

[109]  H Duffau,et al.  Temozolomide for low-grade gliomas , 2007, Neurology.

[110]  J. Dudley,et al.  ALY Is a Common Coactivator of RUNX1 and c-Myb on the Type B Leukemogenic VirusEnhancer , 2007, Journal of Virology.

[111]  Izabela Makałowska,et al.  Identification of human tRNA:m5C methyltransferase catalysing intron-dependent m5C formation in the first position of the anticodon of the pre-tRNA(CAA)Leu , 2006, Nucleic acids research.

[112]  Mark Helm,et al.  Post-transcriptional nucleotide modification and alternative folding of RNA , 2006, Nucleic acids research.

[113]  Xiaoyu Zhang,et al.  Methylation of tRNAAsp by the DNA Methyltransferase Homolog Dnmt2 , 2006, Science.

[114]  T. Omi,et al.  Aly/ REF, a factor for mRNA transport, activates RH gene promoter function , 2005, The FEBS journal.

[115]  R. Shiekhattar,et al.  Linking transcriptional elongation and messenger RNA export to metastatic breast cancers. , 2005, Cancer research.

[116]  Marcin Feder,et al.  Sequence-structure-function studies of tRNA:m5C methyltransferase Trm4p and its relationship to DNA:m5C and RNA:m5U methyltransferases. , 2004, Nucleic acids research.

[117]  D. Johnston,et al.  The Type B Leukemogenic Virus Truncated Superantigen Is Dispensable for T-Cell Lymphomagenesis , 2003, Journal of Virology.

[118]  Kevin Struhl,et al.  TREX is a conserved complex coupling transcription with messenger RNA export , 2002, Nature.

[119]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[120]  M. Schwab,et al.  MYCN amplification and 17q in neuroblastoma: Evidence for structural association , 2001, Genes, chromosomes & cancer.

[121]  L. Montanaro,et al.  p120 expression provides a reliable indication of the rapidity of cell duplication in cancer cells independently of tumour origin , 2000, The Journal of pathology.

[122]  E. Hurt,et al.  The protein Aly links pre-messenger-RNA splicing to nuclear export in metazoans , 2000, Nature.

[123]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[124]  P. Kogner,et al.  Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2 (SSTR2) gene at 17q24 , 1999, British Journal of Cancer.

[125]  M. Green,et al.  A human nuclear-localized chaperone that regulates dimerization, DNA binding, and transcriptional activity of bZIP proteins. , 1999, Molecular cell.

[126]  F. Speleman,et al.  Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. , 1999, The New England journal of medicine.

[127]  R Grosschedl,et al.  ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRalpha enhancer function. , 1997, Genes & development.

[128]  T. Miida,et al.  Two families of Lowe oculocerebrorenal syndrome with elevated serum HDL cholesterol levels and CETP gene mutation , 1997, Acta paediatrica.

[129]  E. Zabarovsky,et al.  Construction of representative NotI linking libraries specific for the total human genome and for human chromosome 3. , 1994, Genomics.

[130]  L. Arthur,et al.  The involvement of a type-B retrovirus in the induction of thymic lymphomas. , 1985, Virology.

[131]  M. Coleman,et al.  Colon cancer survival in the United States by race and stage (2001‐2009): Findings from the CONCORD‐2 study , 2017, Cancer.

[132]  L. Ovchinnikov,et al.  YB‐1 protein: functions and regulation , 2014, Wiley interdisciplinary reviews. RNA.

[133]  A. Protopopov,et al.  Human ALY/BEF gene Map position 17q25.3 , 2004, Chromosome Research.

[134]  M. González-Escribano,et al.  Autoantibodies to transcriptional regulation proteins DEK and ALY in a patient with systemic lupus erythematosus. , 1999, Human immunology.